Wouters P F, Van de Velde M A, Marcus M A, Deruyter H A, Van Aken H
Department of Anesthesiology, University Hospitals Gasthuisberg, Belgium.
Anesth Analg. 1995 Jul;81(1):125-31. doi: 10.1097/00000539-199507000-00025.
The purpose of this study was to examine global and regional hemodynamic changes during induction of anesthesia with eltanolone, a new short-acting steroid hypnotic, as compared to propofol, in chronically instrumented dogs. The effects on cardiac performance were assessed in six animals. Renal and hepatic blood flows were examined in a separate study including five animals. Two doses of each drug were investigated: eltanolone 2.5 and 5 mg/kg and propofol 7.5 and 15 mg/kg. Left atrial filling pressures and cardiac output were not affected by either drug. Maximum rate of increase of left ventricular pressures decreased both with eltanolone (-28% and -40% from awake control for the 2.5 and 5 mg/kg doses, respectively) and with propofol (-19% and -30% from awake controls with 7.5 and 15 mg/kg respectively). In contrast to propofol, eltanolone preserved arterial blood pressure. Propofol lowered systemic vascular resistance (-21% and -39% with the low and high dose, respectively), and only slightly decreased left ventricular wall thickening fraction (-16% and -21%). Eltanolone did not affect systemic vascular resistance but reduced the wall-thickening fraction dose-dependently (-28% and -61%). Propofol, but not eltanolone, induced moderate coronary vasodilation. Hepatic arterial blood flow velocity decreased dose-dependently (-21% and -64%) during eltanolone anesthesia whereas, in contrast, it increased after propofol (+59% and +64%). Renal and portal venous blood flows remained essentially unaltered from awake conditions.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究的目的是,在长期植入仪器的犬类中,研究新型短效类固醇催眠药艾坦诺龙与丙泊酚相比,在麻醉诱导期间的整体和局部血流动力学变化。在六只动物身上评估了对心脏功能的影响。在另一项包括五只动物的单独研究中,检测了肾血流量和肝血流量。研究了每种药物的两个剂量:艾坦诺龙2.5和5mg/kg,丙泊酚7.5和15mg/kg。两种药物均未影响左心房充盈压和心输出量。左心室压力的最大上升速率,使用艾坦诺龙时降低(2.5和5mg/kg剂量分别比清醒对照降低28%和40%),使用丙泊酚时也降低(7.5和15mg/kg分别比清醒对照降低19%和30%)。与丙泊酚不同,艾坦诺龙可维持动脉血压。丙泊酚降低了全身血管阻力(低剂量和高剂量分别降低21%和39%),仅轻微降低左心室壁增厚分数(分别降低16%和21%)。艾坦诺龙不影响全身血管阻力,但剂量依赖性地降低壁增厚分数(分别降低28%和61%)。丙泊酚可诱导中度冠状动脉舒张,而艾坦诺龙则无此作用。在艾坦诺龙麻醉期间,肝动脉血流速度呈剂量依赖性降低(分别降低21%和64%),而相比之下,丙泊酚麻醉后肝动脉血流速度增加(分别增加59%和64%)。肾血流量和门静脉血流量与清醒状态相比基本未改变。(摘要截选至250字)